Jennifer Thompson is the founder and CEO of FAKnostics, LLC, a role she has held since 2014. FAKnostics is a startup diagnostics company dedicated to measuring Focal Adhesion Kinase (FAK) in human tumor biopsies. This measurement aims to determine the suitability of patients for FAK-targeted cancer therapeutics.

The company's approach involves developing an immunohistochemical kit to measure FAK expression.